| NT-I7 for Kaposi Sarcoma in Patients With or Without HIV (NCT04893018) | Fred Hutchinson Cancer Center | 2022-05-23 |
| Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV (NCT04902443) | National Cancer Institute (NCI) | 2021-12-10 |
| Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma (NCT04941274) | National Cancer Institute (NCI) | 2021-09-29 |
| HHV8 and Solid Organ Transplantation (NCT05081141) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2021-09-15 |
| Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis (NCT04742387) | National Cancer Institute (NCI) | 2021-02-04 |
| Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma (NCT04065152) | Assistance Publique - Hôpitaux de Paris | 2021-01-01 |
| A Study of sEphB4-HSA in Kaposi Sarcoma (NCT03993106) | Vasgene Therapeutics, Inc | 2020-09-17 |
| Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma (NCT03469804) | Assistance Publique - Hôpitaux de Paris | 2018-07-01 |
| Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya (NCT03404297) | Indiana University | 2018-03-01 |
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) (NCT03157167) | Navidea Biopharmaceuticals | 2017-12-01 |
| Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma (NCT03050788) | Massachusetts General Hospital | 2017-03-10 |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer (NCT02595866) | National Cancer Institute (NCI) | 2016-04-04 |
| Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma (NCT02659930) | National Cancer Institute (NCI) | 2016-01-13 |
| Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02408861) | National Cancer Institute (NCI) | 2015-10-21 |
| Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. (NCT03296553) | National Institute of Cancerología | 2015-10-01 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors (NCT02080416) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-07-01 |
| Pomalidomide for Kaposi Sarcoma in People With or Without HIV (NCT01495598) | National Cancer Institute (NCI) | 2012-01-10 |
| A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma (NCT01412515) | Institut National de la Santé Et de la Recherche Médicale, France | 2008-06-01 |
| Development of Serologic Assays for Human Herpes Virus-8 (NCT00395278) | National Institutes of Health Clinical Center (CC) | 2006-10-30 |